Cargando…
Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoing in vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study
BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is the most serious and potentially life-threatening iatrogenic complication associated with ovarian stimulation during assisted reproductive technology protocols. The aim of this study was to evaluate the role of dopamine agonist as a preventive...
Autores principales: | Kılıç, Niyazi, Özdemir, Özhan, Başar, Hakan Cevdet, Demircan, Fadime, Ekmez, Fırat, Yücel, Oğuz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637949/ https://www.ncbi.nlm.nih.gov/pubmed/26629467 http://dx.doi.org/10.4103/2231-0770.165121 |
Ejemplares similares
-
Comparison of Cabergoline and Quinagolide in Prevention
of Severe Ovarian Hyperstimulation Syndrome among
Patients Undergoing Intracytoplasmic Sperm Injection
por: Taheripanah, Robabeh, et al.
Publicado: (2018) -
Effect of pigtail catheter application on obstetric outcomes in in vitro fertilization/intracytoplasmic sperm injection pregnancies following hyperstimulation syndrome
por: Çağlar Aytaç, Pınar, et al.
Publicado: (2017) -
The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011) -
The usefulness of metaphase I oocytes in women who undergo controlled ovarian hyperstimulation for intracytoplasmic sperm injection
por: Bilibio, João Paolo, et al.
Publicado: (2021) -
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
por: Rubenfeld, Eryn Sara, et al.
Publicado: (2021)